Telix Pharmaceuticals 2023 Annual General Meeting

Telix Pharmaceuticals held its Annual General Meeting on May 24, 2023, to update shareholders on company operations and activities. The presentation covers Telix's investigational pharmaceutical products, including Illuccix® (Ga-68 gozetotide injection), and discusses business developments, regulatory progress, and financial performance. This document provides summary information for shareholder review and should be read in conjunction with ASX continuous disclosure filings.